CD4 and Granuloma: When CD4+ T-cell counts decrease, the host anti-Mtb immune response decreases, which increases the multiplication of Mtb and prevents granulomas from limiting Mtb. Consequently, the progression and dissemination of Mtb ultimately increase the risk of drug resistance and death.